ESR1 and breast carcinoma: As we have mentioned earlier, accumulating clinical evidence has revealed that SDC1 overexpression is strongly correlated with ER and PR negativity, high-grade and large-size breast cancer tumors, and subsequent poor clinical outcomes [32,34,86,87,88].